Report DMCA Temozolomide showed rapid activity in a patient with refractory CNS monomorphic epitheliotropic T cell lymphoma
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.